Angiocrine Bioscience

Paul Finnegan, M.D., CEO

Oct. 12 | 1:30pm | BlueRock Therapeutics Ballroom

San Diego, CA

In-person Presentation
Angiocrine Bioscience aims to transform medicine by harnessing the natural powers of endothelial cells to enable the repair of tissues and organs for patients with life-threatening and debilitating conditions through its proprietary, genetically engineered, E-CEL technology platform.

By using this website you agree to accept our Privacy Policy and Terms & Conditions